title: Editorial: combination therapy for systemic hypertension (15 September 1995).
authors.forename: G Y
authors.initials: GY
authors.lastname: Lip
authors.forename: R
authors.initials: R
authors.lastname: Roberts
authors.forename: S
authors.initials: S
authors.lastname: Gates
authors.forename: M
authors.initials: M
authors.lastname: Beevers
authors.forename: R C
authors.initials: RC
authors.lastname: Orsborn
authors.forename: D G
authors.initials: DG
authors.lastname: Beevers
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D004232:Diuretics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors